Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019.
dc.contributor.author | Plachouras, Diamantis | |
dc.contributor.author | Lötsch, Felix | |
dc.contributor.author | Kohlenberg, Anke | |
dc.contributor.author | Monnet, Dominique L | |
dc.date.accessioned | 2021-05-02T19:27:28Z | |
dc.date.available | 2021-05-02T19:27:28Z | |
dc.identifier.pmid | 32234118 | |
dc.identifier.doi | 10.2807/1560-7917.ES.2020.25.12.2000240 | |
dc.identifier.uri | http://hdl.handle.net/10029/624919 | |
dc.description.abstract | Between January 2018 and May 2019, 349 cases of Candida auris were reported in the European Union/European Economic Area*, 257 (73.6%) colonisations, 84 (24.1%) bloodstream infections, seven (2.0%) other infections and one case of unknown infection/colonisation status (0.3%). Most cases (97.1%, n = 339) were reported from Spain or the United Kingdom, but also for the first time in Greece, the Netherlands and Poland. Laboratory capacity and preparedness has improved since January 2018. | en_US |
dc.language.iso | en | en_US |
dc.subject | Candida auris | en_US |
dc.subject | epidemiology | en_US |
dc.subject | laboratory capacity | en_US |
dc.subject | preparedness | en_US |
dc.title | Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1560-7917 | |
dc.identifier.journal | Euro Surveill 2020; 25(12):pii.2000240 | en_US |
dc.source.journaltitle | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | |
dc.source.volume | 25 | |
dc.source.issue | 12 | |
dc.source.country | Sweden |